These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

286 related articles for article (PubMed ID: 23335744)

  • 1. Reduced drug uptake in phenotypically resistant nutrient-starved nonreplicating Mycobacterium tuberculosis.
    Sarathy J; Dartois V; Dick T; Gengenbacher M
    Antimicrob Agents Chemother; 2013 Apr; 57(4):1648-53. PubMed ID: 23335744
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro activities of linezolid against clinical isolates of Mycobacterium tuberculosis complex isolated in Taiwan over 10 years.
    Huang TS; Liu YC; Sy CL; Chen YS; Tu HZ; Chen BC
    Antimicrob Agents Chemother; 2008 Jun; 52(6):2226-7. PubMed ID: 18391030
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro susceptibility of Mycobacterium tuberculosis clinical isolates to garenoxacin and DA-7867.
    Vera-Cabrera L; Castro-Garza J; Rendon A; Ocampo-Candiani J; Welsh O; Choi SH; Blackwood K; Molina-Torres C
    Antimicrob Agents Chemother; 2005 Oct; 49(10):4351-3. PubMed ID: 16189119
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro and in vivo activities of three oxazolidinones against nonreplicating Mycobacterium tuberculosis.
    Zhang M; Sala C; Dhar N; Vocat A; Sambandamurthy VK; Sharma S; Marriner G; Balasubramanian V; Cole ST
    Antimicrob Agents Chemother; 2014 Jun; 58(6):3217-23. PubMed ID: 24663022
    [TBL] [Abstract][Full Text] [Related]  

  • 5. First linezolid-resistant clinical isolates of Mycobacterium tuberculosis.
    Richter E; Rüsch-Gerdes S; Hillemann D
    Antimicrob Agents Chemother; 2007 Apr; 51(4):1534-6. PubMed ID: 17242139
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Importance of the efflux pump systems in the resistance of Mycobacterium tuberculosis to fluoroquinolones and linezolid.
    Escribano I; Rodríguez JC; Llorca B; García-Pachon E; Ruiz M; Royo G
    Chemotherapy; 2007; 53(6):397-401. PubMed ID: 17934259
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interaction between linezolid and Mycobacterium tuberculosis in an experimental in vitro model.
    Cremades R; Rodríguez JC; Garcia-Pachón E; Galiana A; Ruiz-García M; López P; Royo G
    APMIS; 2011 Apr; 119(4-5):304-8. PubMed ID: 21492231
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Streptomycin-starved Mycobacterium tuberculosis 18b, a drug discovery tool for latent tuberculosis.
    Zhang M; Sala C; Hartkoorn RC; Dhar N; Mendoza-Losana A; Cole ST
    Antimicrob Agents Chemother; 2012 Nov; 56(11):5782-9. PubMed ID: 22926567
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro activities of linezolid against clinical isolates of Mycobacterium tuberculosis that are susceptible or resistant to first-line antituberculous drugs.
    Alcalá L; Ruiz-Serrano MJ; Pérez-Fernández Turégano C; García De Viedma D; Díaz-Infantes M; Marín-Arriaza M; Bouza E
    Antimicrob Agents Chemother; 2003 Jan; 47(1):416-7. PubMed ID: 12499228
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro activity of linezolid against clinical isolates of Mycobacterium tuberculosis, including multidrug-resistant and extensively drug-resistant strains from Beijing, China.
    Yang C; Lei H; Wang D; Meng X; He J; Tong A; Zhu L; Jiang Y; Dong M
    Jpn J Infect Dis; 2012; 65(3):240-2. PubMed ID: 22627306
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Post-antibiotic effects of linezolid and other agents against Mycobacterium tuberculosis.
    Hui M; Au-Yeang C; Wong KT; Chan CY; Yew WW; Leung CC
    Int J Antimicrob Agents; 2008 Apr; 31(4):395-6. PubMed ID: 18272351
    [No Abstract]   [Full Text] [Related]  

  • 12. Genome-wide expression profiling of the response to linezolid in Mycobacterium tuberculosis.
    Liang J; Tang X; Guo N; Zhang K; Guo A; Wu X; Wang X; Guan Z; Liu L; Shen F; Xing M; Liu L; Li L; Yu L
    Curr Microbiol; 2012 Jun; 64(6):530-8. PubMed ID: 22388809
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro activities of PNU-100480 and linezolid against drug-susceptible and drug-resistant Mycobacterium tuberculosis isolates.
    Yip PC; Kam KM; Lam ET; Chan RC; Yew WW
    Int J Antimicrob Agents; 2013 Jul; 42(1):96-7. PubMed ID: 23684005
    [No Abstract]   [Full Text] [Related]  

  • 14. In vitro activity of linezolid against Mycobacterium tuberculosis strains isoalted from Western Turkey.
    Ermertcan S; Hosgor-Limoncu M; Erac B; Tasli H; Cavusoglu C; Bozkurt H
    Jpn J Infect Dis; 2009 Sep; 62(5):384-5. PubMed ID: 19762990
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Evaluation of the mycobacterium efficacy of linezolid in vitro].
    Huang HR; Yu X; Jiang GL; Dai GM; Bi ZQ; Ma Y
    Zhonghua Jie He He Hu Xi Za Zhi; 2011 Aug; 34(8):575-8. PubMed ID: 22168977
    [TBL] [Abstract][Full Text] [Related]  

  • 16. rplC T460C identified as a dominant mutation in linezolid-resistant Mycobacterium tuberculosis strains.
    Beckert P; Hillemann D; Kohl TA; Kalinowski J; Richter E; Niemann S; Feuerriegel S
    Antimicrob Agents Chemother; 2012 May; 56(5):2743-5. PubMed ID: 22371899
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Susceptibility of clinical Mycobacterium tuberculosis isolates to a potentially less toxic derivate of linezolid, PNU-100480.
    Alffenaar JW; van der Laan T; Simons S; van der Werf TS; van de Kasteele PJ; de Neeling H; van Soolingen D
    Antimicrob Agents Chemother; 2011 Mar; 55(3):1287-9. PubMed ID: 21199931
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bioluminescence for assessing drug potency against nonreplicating Mycobacterium tuberculosis.
    Vocat A; Hartkoorn RC; Lechartier B; Zhang M; Dhar N; Cole ST; Sala C
    Antimicrob Agents Chemother; 2015 Jul; 59(7):4012-9. PubMed ID: 25896710
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Second-line drug susceptibilities of multidrug-resistant tuberculosis strains isolated in Thailand: an update.
    Chaiprasert A; Srimuang S; Tingtoy N; Makhao N; Sirirudeeporn P; Tomnongdee N; Theankeaw O; Charoensook S; Leechawengwongs M; Prammananan T
    Int J Tuberc Lung Dis; 2014 Aug; 18(8):961-3. PubMed ID: 25199012
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Promising antituberculosis activity of the oxazolidinone PNU-100480 relative to that of linezolid in a murine model.
    Williams KN; Stover CK; Zhu T; Tasneen R; Tyagi S; Grosset JH; Nuermberger E
    Antimicrob Agents Chemother; 2009 Apr; 53(4):1314-9. PubMed ID: 19075058
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.